Epiglottitis due to nontypeable Haemophilus influenzae in a vaccinated child.
Once a prevalent disease, acute epiglottitis in children has become a rare entity. The introduction of the Haemophilus influenzae type b vaccine has had a dramatic impact on the number of invasive infections caused by this organism. However, physicians must be aware that epiglottitis may result from vaccine failures or from infection with other pathogenic organisms. Vaccinated children with epiglottitis present in a similar fashion to those who are not vaccinated. We present a rare case of acute epiglottitis in a fully vaccinated child due to nontypeable H. influenzae and discuss the clinical presentation and management.
Rogers
Derek J
DJ
Madigan Army Medical Center, Otolaryngology-Head and Neck Surgery, Fitzsimmons Dr, Tacoma, WA 98431, United States. derek.john.rogers@amedd.army.mil
Sie
Kathleen C Y
KC
Manning
Scott C
SC
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004826:Epiglottitis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D006192:Haemophilus Infections / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control*; D019741:Haemophilus influenzae type b / Q000302:isolation & purification*; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D008297:Male; D013407:Sulbactam / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D007252:Influenza Vaccines; C035444:sultamicillin; D014640:Vancomycin; D000667:Ampicillin; D013407:Sulbactam